2023
Factors associated with receiving results and attending colposcopy in patients with positive HPV screens in Mexico City
León-Maldonado L, Hernández-Ramírez R, Torres-Ibarra L, Spiegelman D, Sheth S, Lazcano E, Cadena-Fiscal J, Salmerón J. Factors associated with receiving results and attending colposcopy in patients with positive HPV screens in Mexico City. Preventive Medicine Reports 2023, 35: 102347. PMID: 37593354, PMCID: PMC10428024, DOI: 10.1016/j.pmedr.2023.102347.Peer-Reviewed Original ResearchPercent of participantsColposcopy appointmentHealthcare facilitiesHigh-risk human papillomavirusMultivariable logistic regressionHealthcare system factorsScreening resultsPositive screening resultsColposcopy adherenceColposcopy clinicHPV screenPrevious PapMedian ageCervical cancerPap testHuman papillomavirusHigh school educationPatientsGreater adherenceExperienced nursesGood complianceLogistic regressionScheduling appointmentsLimited staff availabilityAdherenceAssociation between cancer stigma and cervical cancer screening uptake among women of Dhulikhel and Banepa, Nepal
Paneru B, Karmacharya A, Bharati A, Makaju S, Adhikari B, Kafle D, Shakya S, Spiegelman D, Seth S, Stangl A, Shrestha A, Shrestha A. Association between cancer stigma and cervical cancer screening uptake among women of Dhulikhel and Banepa, Nepal. PLOS ONE 2023, 18: e0285771. PMID: 37200234, PMCID: PMC10194964, DOI: 10.1371/journal.pone.0285771.Peer-Reviewed Original ResearchConceptsCervical cancer screening uptakeCancer screening uptakeScreening uptakeMultivariable logistic regressionCancer Stigma ScaleCancer stigmaCervical cancerAge of menarcheFirst sexual intercourseLogistic regressionNepalese womenSexual intercourseReproductive health variablesCervical cancer screeningEffective screening programsSemi-urban areasCross-sectional studyPercent of womenMean total scoreFamily planning usersScreening servicesCancer screeningCommon cancerDisease burdenScreening program
2020
Adjunctive testing by cytology, p16/Ki‐67 dual‐stained cytology or HPV16/18 E6 oncoprotein for the management of HPV16/18 screen‐positive women
Torres‐Ibarra L, Lorincz AT, Wheeler CM, Cuzick J, Hernández‐López R, Spiegelman D, León‐Maldonado L, Rivera‐Paredez B, Méndez‐Hernández P, Lazcano‐Ponce E, Salmerón J. Adjunctive testing by cytology, p16/Ki‐67 dual‐stained cytology or HPV16/18 E6 oncoprotein for the management of HPV16/18 screen‐positive women. International Journal Of Cancer 2020, 148: 2264-2273. PMID: 33252834, DOI: 10.1002/ijc.33414.Peer-Reviewed Original ResearchConceptsHPV16/18-positive womenP16/KiLiquid-based cytologyHPV16/18-E6 oncoproteinColposcopy referralAdjunctive testingCervical intraepithelial neoplasia grade 2Dual-stained cytologyUnnecessary colposcopy referralsHigh-risk HPVCervical cancer screeningScreen-positive womenE6 oncoproteinCancer risk stratificationNormal cytologyPositive womenNonprogressive infectionRisk stratificationCervical cancerInvasive cancerCancer screeningDirect referralPositivity rateGrade 3Grade 2